Flagship Pioneering
Senior Analyst, Drug Development & Clinical Strategy
$112K–$155K
Cambridge, MA USA +1 · Senior · Full-time · Posted Sep 28, 2026
- Location
- Cambridge, MA USA
Quotient Therapeutics, Inc. - Experience
- 3+ years; 4-6+ years of industry experience is desirable.
- Education
- Bachelor's degree in a health sciences discipline or a related field; an advanced degree is desirable.
About the job
Supports strategic decisions across a drug development pipeline by analyzing markets, clinical and commercial data, and development opportunities.
What you'll do
- Assess disease-area markets, conduct competitive and market analyses, and validate findings with external experts.
- Build valuation models, forecasts, dashboards, and analytical frameworks to inform investment, business development, and development planning.
- Prototype, test, and help deploy AI-enabled tools and analytical resources for these analyses.
What they ask for
- Bachelor's degree in a health sciences discipline or related field.
- 3+ years working in or with pharmaceutical or biotech companies in product planning or commercial strategy teams.
- Experience in at least one listed disease segment: Cardiovascular, renal, metabolic, oncology, or autoimmune diseases.
- Familiarity with drug development strategy and regulatory pathways; experience with healthcare or life-sciences databases and market research tools.
Nice to have
- MD, PhD, or other advanced degree; 4-6+ years of industry experience.
- Knowledge of genomic-based approaches to drug target discovery.
Pay
$112,000 - $154,550 USD base salary
AI focus
Prototype, test, and help deploy AI-enabled tools and agents to support analyses; application materials may also be reviewed using AI-assisted screening tools.
Model-written summary · the original posting is authoritative